Human neutrophil antigens (HNAs) have been categorized in 5 systems: HNA-1, -2, -3, -4, and -5 comprising different glycoproteins encoded by FCGR3B, CD177, SLC44A2, ITGAM, and ITGAL genes, respectively.
genotype frequencies among northeastern Thais were similar to central Thais. 8 To determine more convenient HNA genotyping, multiplex PCR has been applied to reduce costs and time-consuming tasks by performing the simultaneous detection of HNA-1, -3, -4, and -5. 9 The data of HNA among southern Thais remain unknown.
Regarding the HNA-1 system, only one HNA-1 null was found among northeastern Thais. 8 The HNA-1 null phenotype occurs among individuals with homozygous chromosomal deletion involving the FCGR3B gene deficiency. 10, 11 Several cases of neonatal neutropenia caused by HNA-1 antibodies of FCGR3B-deficient mothers were reported in different populations. 10, 12, 13 Regarding related studies, genotyping of the HNA-1 null individuals using PCR-SSP and/or multiplex PCR showed no bands of FCGR3B*01, FCGR3B*02, and FCGR3B*03 allele detections. 8, 9 The PCR-restriction fragment length polymorphism (RFLP) is suggested to be used to confirm FCGR3B-deficient individuals. 10, 11 This study aimed to determine HNA-1, -3, -4, and -5 frequencies among southern Thais using multiplex PCR and to develop HNA-1 null detection.
| MATERIAL SANDME THODS

| Studypopulation
Peripheral venous blood was collected in EDTA-anticoagulated blood from 427 unrelated healthy blood donors from Regional Blood
Centre 12th Songkhla, Thai Red Cross Society, Songkhla, Thailand. 
| Laboratorytesting
| GenomicDNAextractionandHNA-1,-3, -4,and-5genotyping
Genomic DNA was extracted from all samples using a Genomic DNA extraction kit (REAL Genomics, RBC Bioscience, Taipei, Taiwan) and was then stored at −20°C until used for genotyping. In addition, HNA-1, -3, -4, and -5 genotyping, using multiplex PCR, was performed as previously described. 9 Briefly, the multiplex PCR for HNA-1a, -1b, -1c, -3a, -3b, -4a, -4b, -5a, and -5b genotyping contained four multiple reaction sets (A to D) of each different amplification target per mix. Each multiplex set contained two to three HNA-specific primer pairs, and one human growth hormone (HGH)-specific primer pair served as the internal control.
PCR reaction mixtures consisted of 10 μL of the 2× PCR reaction mixture (OnePCR Plus, GeneDirex, New Taipei City, Taiwan), 1 μL (50-150 ng) of genomic DNA, 1 μL of each HNA-specific primer, PCR products were electrophoresed at 100 volts with a 1.5% agarose gel using 1× tris-borate-ethylenediaminetetraacetic acid (TBE)
buffer. Products were visualized under a blue-light transilluminator.
All DNA samples of southern Thai blood donors were tested, and the known DNA controls were run through the entire test along with the unknown samples. 
| DeterminationofHNA-1nullbyPCR-RFLP
For HNA-1 null determination, the FCGR3B gene deletion was identified using PCR-RFLP, as previously described with some modifications. 10 The amplified a 507-bp fragment contained part of 3′ 
| PCR-SSPdevelopmentforHNA-1 nulldetection
The HNA-1 null was detected using an in-house PCR-SSP technique. 
Individual tests to identify
| DNAsequencing
Twenty selected DNA samples of HNA-1a, -1b, -1c, and HNA-1 null tested by PCR-SSP were sequenced to confirm the HNA-1 null. A fragment of 507 bp was obtained from PCR amplification of both FCGR3A and FCGR3B target genes, containing SNP, rs#374752953 (NC_000001.11:g.161624517A>G). The PCR amplification for DNA sequencing was identical to HNA-1 null determination by PCR-RFLP. Thereafter, the PCR products were purified using a gel extraction kit (AccuPrep Gel Purification, Bioneer, Inc., Daejeon, Korea), and eluted fragments were then sequenced using those PCR primers.
| Statisticalanalysis
Gene and allele frequencies were calculated using the gene-counting method. The chi-square test of homogeneity was used to determine differences between southern Thais and those reported in other Thai populations. [5] [6] [7] [8] A P value of equal or less than 0.05 was considered significant. 
| RE SULTS
| HNA-1,-3,-4,and-5genotypingamong southernThais
| ComparisonofHNAgenotypeandallele frequenciesinThaipopulations
The distribution of HNA-1, -3, -4, and -5 genotypes based on the allele frequencies was compared with those reported in other Thai populations (Table 1) . The allele frequencies of ITGAL*01 and ITGAL*02 were found at 0.656 and 0.344 among southern Thais, respectively, and the frequency of ITGAL*01 was significantly lower than northern and central Thais (P < 0.001).
F I G U R E 1 A representative agarose gel electrophoresis profile to detect HNA-1, -3, -4, and -5 genotyping using multiplex PCR. The genotype was deduced from the presence or absence of amplification products specific for HNA alleles. Multiplex set A identified HNA-1a and -5a with a PCR product size of 141 and 297 bp, while multiplex set B identified HNA-1b and HNA-5b with a PCR product size of 219 and 297 bp. Additionally, multiplex set C identified HNA-4a, 1c, and -3a with a PCR product size of 124, 191, and 289 bp, whereas multiplex set D identified HNA-4b and HNA-3b with a PCR product size of 124 and 289 bp. In each multiplex set, the HGH internal control gave an expected band of 434 bp. Lane M: 100-bp DNA ladder marker (GeneRuler 100 bp, Fermentas, Carlsbad, CA, USA), lanes 1A to 1D, sample SM025: HNA-1a1b1c, -3a3b, -4a4a, and -5a5a, Lanes 2A to 2D, sample SM237: HNA-1 null, -3a3a, -4a4a, and -5a5b
| HNA-1nulldeterminationandconfirmation
In two samples of the HNA-1 null (SM237 and SM402), the mul- Hence, the PCR-RFLP of the FCGR3B gene in these two samples did not detect the 282-bp fragment after TaqI digestion ( Figure 2 ). This suggested that the FCGR3B gene might have been deleted in both donors. Moreover, the validity testing of multiplex PCR and PCR-RFLP was performed using 20 randomly selected DNA samples including 2 HNA-1 null samples, and the results were in agreement with DNA sequencing.
| DetectionoftheHNA-1nullbyPCR-SSP
In this study, we developed an in-house PCR-SSP for FCGR3B
gene deletion of the HNA-1 null. Two primer sets were used to determine the FCGR3A and FCGR3B genes. The first set identified 
| D ISCUSS I ON
Antibodies specific for HNA-1, -2, and -3 can induce TRALI after blood transfusions. Moreover, the passive transferring antibodies of HNA-1 to -5, caused by maternal alloimmunization, are implicated in neonatal neutropenia. 1, 14 Hence, HNA genotyping is used not only to confirm whether the patients produced the corresponding HNA antibodies with deliberate immunization but also to screen appropriate antigen-negative blood.
This study was the first to report frequencies of HNA-1, -3, -4, and -5 among southern Thai blood donors. They were Thai-Muslims living in the three southern border provinces of Pattani, Yala, and
Narathiwat that have their own specific religion, culture, and life- gene fragments from the restriction site of TaqI (rs#374752953).
After implementing this technique among 427 subjects from southern Thais, the results were in agreement with multiplex PCR and PCR-RFLP. In addition, validity testing among 20 randomly selected subjects including 2 subjects with FCGR3B deficiency (HNA-1 null)
was consistent with DNA sequencing. Antibodies against HNA-1 can be involved in neutropenia and TRALI. A related study revealed that individuals with FCGR3B deficiency were strongly influenced in systemic autoimmunity susceptibility. 14, 19 Therefore, screening for FCGR3B deficiency using PCR-SSP may be helpful in identifying patients with either HNA-1 alloimmunization or a risk of systemic sclerosis.
In conclusion, HNA-1, -3, -4, and -5 frequencies were firstly reported among southern Thais. Only HNA-4 frequencies were similar to those of other Thai populations. The indeterminate results of multiplex PCR for HNA-1 genotyping led to establishing HNA-1 null detection by PCR-SSP, which is simple, convenient and costeffective and can be used to identify FCGR3B deficiency. 
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